BrainBlog

BrainBlog

Sunday, March 28, 2010

Multiple Sclerosis (MS): The SURPASS Clinical Trial

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS):
ClinicalTrials.gov Description

===
Corporate press release

===

No comments: